Phosphodiesterase 5 inhibitors for erectile dysfunction. - Wikidata - awgldk - TriplyDB

Phosphodiesterase 5 inhibitors for erectile dysfunction.

Phosphodiesterase 5 inhibitors for erectile dysfunction.

http://www.wikidata.org/entity/Q36154866

about

Current use of phosphodiesterase inhibitors in urology Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials Conformational Variations of Both Phosphodiesterase-5 and Inhibitors Provide the Structural Basis for the Physiological Effects of Vardenafil and Sildenafil Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function Alzheimer's disease and age-related memory decline (preclinical)Repurposing human PDE4 inhibitors for neglected tropical diseases. Evaluation of analogs of the human PDE4 inhibitor GSK-256066 as inhibitors of PDEB1 of Trypanosoma brucei.Gene and stem cell therapy for erectile dysfunction.The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.Evaluation of the effect of different doses of low energy shock wave therapy on the erectile function of streptozotocin (STZ)-induced diabetic rats Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.The role of interventional radiology in the diagnosis and management of male impotence.Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction.Effect of low-energy shockwave therapy on angiogenic factors in the penile tissue of diabetic rats.The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis.A gas chromatography/mass spectrometry method for the determination of sildenafil, vardenafil and tadalafil and their metabolites in human urine.Transplantation KCNMA1 modified bone marrow-mesenchymal stem cell therapy for diabetes mellitus-induced erectile dysfunction.Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction.The effects of the phosphodiesterase type 5 inhibitor vardenafil on cognitive performance in healthy adults: a behavioral-electroencephalography study.cAMP-dependent post-translational modification of neuronal nitric oxide synthase neuroprotects penile erection in rats.Epistaxis after PDE-5 inhibitors misuse.Dickkopf2 rescues erectile function by enhancing penile neurovascular regeneration in a mouse model of cavernous nerve injury.Comparative efficacy of tamsulosin versus tadalafil as medical expulsive therapy for distal ureteric stones.

P2860

Q26795512-79D44F41-87D5-4E25-B862-EB7D9F5FF96D Q26800403-D789B1E1-F097-4EDE-927E-506BA56E0928 Q27648887-B93650D7-BEA1-45A1-80D8-B541E9EE9988 Q28510096-D90FE7E8-9E36-45F4-B3EE-B8618AB9E549 Q35041190-2AEBD39C-329C-4AAA-A15A-5E1D11A0067E Q35270030-487F8CDB-DA99-4234-8042-04F78020C4CE Q36359862-87ED4ED3-3B3B-41B2-B584-2D07A175619F Q36599937-D0871743-7248-4BFC-BC5B-21923AC9A8AE Q36913791-FF5DE895-8724-4094-8D0A-898BB5257B42 Q37245947-452476FE-4554-46D5-9B0F-A59DCF4DAF1D Q38063167-57685103-3DBD-4353-88BF-9957B46AAE7F Q38126948-073AB9F6-8D34-4ECF-A72D-B793C7B03638 Q38191882-F864D1D0-61E6-418C-9BEC-44132E0A7EE4 Q40970236-B25ABEC5-E799-4BFD-94E3-5DC4FBF24077 Q42989291-89E5663B-CE34-4921-8807-BC5AC4C60A72 Q43058806-E12B62AE-DB4A-448A-B5C4-F254A2B9C482 Q44932684-95537A11-ADC5-4C6B-BD59-7BA8E6F8CE97 Q45863380-A084ECD2-F32E-4B5D-A3F7-070AEDE3822D Q46077750-475E8750-43B0-4936-8C17-D1A3BC04C3D3 Q46324991-7485ECE9-A433-4484-A43F-3F32D5AA03EF Q46656635-3E0EEA13-EB6F-4DBC-B349-310D2EE97A9D Q47155631-6CC740BC-515D-425F-B372-FF77B873995C Q49397675-790F3405-050A-4C6B-8FFE-899594823247

P2860

Phosphodiesterase 5 inhibitors for erectile dysfunction.

http://www.wikidata.org/entity/Q36154866

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Phosphodiesterase 5 inhibitors for erectile dysfunction.

@ast

Phosphodiesterase 5 inhibitors for erectile dysfunction.

@en

type

label

Phosphodiesterase 5 inhibitors for erectile dysfunction.

@ast

Phosphodiesterase 5 inhibitors for erectile dysfunction.

@en

prefLabel

Phosphodiesterase 5 inhibitors for erectile dysfunction.

@ast

Phosphodiesterase 5 inhibitors for erectile dysfunction.

@en

P1433

Q36154866-FB86523A-72E4-4F84-AC63-4BB6030B6B59

P1476

Q36154866-1A818F08-3533-4C0B-891A-70EEE6FFE0A1

P2093

Q36154866-7160B810-F71A-46AA-8647-49375DF6AF88

Q36154866-9691150E-B752-41D9-89D9-6A926C4B177D

Q36154866-A24823C6-58C7-44C3-A13B-84BE01B3C325

Q36154866-CF446EAC-DB5C-4057-A19E-C53EBACD6AA7

Q36154866-EDF8DF0E-F061-4666-9DC7-B28D5D291850

P2860

Q36154866-07FA47C6-682C-4BC2-A4F9-C4F3E57EAFB8

Q36154866-0EE64E1C-3ACE-40E5-838C-DB4274F48C45

Q36154866-10961775-7D8F-4D63-89CC-177F0EEC9204

Q36154866-158CA6DF-90B4-4CCB-8DE6-E8E49F7CD3AF

Q36154866-219D4159-A9A0-40F9-B124-EA7AC1D037F5

Q36154866-2636E45C-DEFB-4631-9763-53CAEA44FA3E

Q36154866-2E6FA0E4-B9DD-4B65-B848-06C9E638528A

Q36154866-322B6E6E-3CE5-490E-A8FD-93D2CFA1B1A7

Q36154866-38C1A83C-6BB9-4FB2-931A-E0EFB95DFA5A

Q36154866-3CD9E5C7-2C1B-47FB-93C3-85656CFFF1B3

P304

Q36154866-A3041400-3BD3-4C50-B16C-71C981C7A8E3

P31

Q36154866-991C088E-EBB5-4324-A51D-A50ABF8B4E65

P356

Q36154866-C0971F53-0F79-4571-A470-2D74C6D1B000

P407

Q36154866-B7A94218-A9D0-4F4F-A134-B8139CDA2A9D

P433

Q36154866-E38846C6-E64B-40F1-B6B5-C823BA042678

P478

Q36154866-FAD67DBA-D703-4534-86DB-26512A391EBC

P577

Q36154866-F4B2A006-2C93-4C45-A87B-5DE2026F5CD8

P5875

Q36154866-B95B6C10-2E4A-462F-9832-07A90DAE5964

P698

Q36154866-EE340FAD-0DBE-4C6D-A6B0-5534D9F2876D

P356

P1433

Annals of Pharmacotherapy

P1476

Phosphodiesterase 5 inhibitors for erectile dysfunction.

@en

P2093

Danial E Baker

http://www.w3.org/2001/XMLSchema#string

Jack E Fincham

http://www.w3.org/2001/XMLSchema#string

Jason L Iltz

http://www.w3.org/2001/XMLSchema#string

R Keith Campbell

http://www.w3.org/2001/XMLSchema#string

Stephen M Setter

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies.

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.

Sildenafil (Viagra) for the treatment of erectile dysfunction in men with diabetes.

The impact of first-line antihypertensive drugs on erectile dysfunction.

The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction.

2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a practical summary for emergency physicians.

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

Vardenafil: update on clinical experience.

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up.

P304

1286-1295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1E487

http://www.w3.org/2001/XMLSchema#string

P407

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7800209

http://www.w3.org/2001/XMLSchema#string

P698

15941818

http://www.w3.org/2001/XMLSchema#string